For many children with high-risk neuroblastoma, receiving two separate stem cell transplants is more beneficial than receiving one, according to the results of an NCI-supported clinical trial conducted by the Children’s Oncology Group.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2kPQILE
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2kPQILE